Zobrazeno 1 - 10
of 50
pro vyhledávání: '"Vicki Osborne"'
Publikováno v:
Journal of Health Research, Vol 34, Iss 4, Pp 283-294 (2020)
Purpose – This study examined how youth would mitigate non-medical use of prescription medication among their peers. Design/methodology/approach – The National Monitoring of Adolescent Prescription Stimulants Study (N-MAPSS) was conducted as an i
Externí odkaz:
https://doaj.org/article/44ea545da67d40799a66e2565bac1a9f
Autor:
Sandeep Dhanda, Alison Evans, Debabrata Roy, Vicki Osborne, Adam Townsley, Graça Coutinho, Anuradha Kulasekaran, Saad Shakir
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Oral non-steroidal anti-inflammatory drugs (NSAIDs) are known to be associated with an increased risk of bleeding. The NSAID, flurbiprofen, in the form of 8.75 mg lozenge or oromucosal spray is indicated for the symptomatic relief of sore throat. Des
Externí odkaz:
https://doaj.org/article/8b9da8f6befd43d29aae459ef13d66b6
Autor:
Vicki Osborne, Saad A. W. Shakir
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2021)
Externí odkaz:
https://doaj.org/article/4e9f042b601a49bdb8addea21510af81
Publikováno v:
BMJ Open, Vol 10, Iss 11 (2020)
Objectives To evaluate the short-term (12 weeks) safety and utilisation of rivaroxaban prescribed to new-user adult patients for the treatment of deep vein thrombosis and pulmonary embolism and for the prevention of recurrent deep vein thrombosis and
Externí odkaz:
https://doaj.org/article/b5337af014994b7594951ea488e1b3ee
Publikováno v:
Therapeutic Advances in Psychopharmacology, Vol 10 (2020)
Background: This study was designed to monitor the short-term (up to 12 weeks) use and safety of quetiapine (Seroquel) extended release (XL) and quetiapine immediate release (IR) prescribed to patients with a clinical diagnosis of schizophrenia, and/
Externí odkaz:
https://doaj.org/article/1bc2f40acf624ee4b931cdecd2583bee
Publikováno v:
PLoS ONE, Vol 15, Iss 10, p e0240489 (2020)
IntroductionAlthough the direct oral anticoagulant rivaroxaban is recommended for stroke prevention in patients with non-valvular atrial fibrillation based on Phase III clinical trials, there is still a need for additional safety data from everyday c
Externí odkaz:
https://doaj.org/article/b93074173c9c4ad6a88b836f15b5d432
Publikováno v:
Drug Safety
Osborne, V, Lane, S L & Shakir, S A W 2021, ' The role of the contextual cohort to resolve some challenges and limitations of comparisons in pharmacoepidemiology ', Drug Safety . https://doi.org/10.1007/s40264-021-01074-y
Osborne, V, Lane, S L & Shakir, S A W 2021, ' The role of the contextual cohort to resolve some challenges and limitations of comparisons in pharmacoepidemiology ', Drug Safety . https://doi.org/10.1007/s40264-021-01074-y
In pharmacoepidemiology, comparison studies can provide a useful estimate of the level of increased or decreased risk of specific events with a medication (through a measure of effect). A key focus of pharmacoepidemiological studies is the safety and
Autor:
Vicki Osborne
Publikováno v:
Current Opinion in Psychiatry
PURPOSE OF REVIEW: Opioid use is prevalent in the United Kingdom and prior to the COVID-19 pandemic it had been recognized that the safety of opioids was an important issue to be monitored by the UK medicines regulatory agency. With the emergence of
Publikováno v:
J Health Res
PurposeThis study examined how youth would mitigate non-medical use of prescription medication among their peers.Design/methodology/approachThe National Monitoring of Adolescent Prescription Stimulants Study (N-MAPSS) was conducted as an interview co
Publikováno v:
BMJ Evidence-Based Medicine
BackgroundPrior to approval in the European Union, a systematic benefit-risk assessment was required to compare buprenorphine implant to sublingual buprenorphine as part of the license application to the European Medicines Agency.ObjectiveThe Benefit